According to Business Research Insights the Urokinase Market expected to exhibit a CAGR of 5.2% by 2033. The "Urokinase Market" Research is your essential resource for understanding the current ...

2 Evidence-Based Medicine Center, School of Basic Medical Sciences, Lanzhou University, Lanzhou, China 3 The First Clinical Medical College of the First Hospital of Lanzhou University, Lanzhou, China ...

Microbix's CEO, Cameron Groome, will undertake a series of 18 one-on-one meetings with growth company equity investors during ...

The results increase “my confidence that this approach has merit,” Lauren Sansing says. More trials are on the way.

Researchers identified two anoikis-related genes linked with CTEPH, and that may serve as diagnostic biomarkers or treatment ...

Researchers found that while sweat biomarkers remain stable, plasma biomarkers show significant inflammatory changes after a ...

These enzymes belong to one of two families, the MMPs and the serine proteinases. Serine proteinases include cathepsin G, proteinase 3, and urokinase-type plasminogen activator. Among its many ...

Overall, strong Q1 revenues and improved margins led to net income of $856,962 without any Kinlytic-related revenues versus Q1 2024 net income of $2,455,379 inclusive of Kinlytic-related revenues.

Telephone participation in the webinar can be arranged by contacting Microbix or Adelaide Capital at the contact numbers provided at the end of this news release. A replay of the webinar will also be ...

Visit us on Facebook. Opens in a new tab or window Visit us on X. Opens in a new tab or window Visit us on Instagram. Opens in a new tab or window Visit us on LinkedIn. Opens in a new tab or ...

Microbix Biosystems Inc. ( OTCQX:MBXBF) Q1 2025 Earnings Conference Call February 13, 2025 11:00 AM ET Deborah Honig - Investor Relations Cameron Groome - Chief Executive Officer Jim Currie - Chief ...